FDA recalls some Heparin in U.S.

[Guest guest]

The U.S. Food and Drug Administration and B. Braun Medical Inc. have notified

health care professionals of a nationwide U.S., voluntary recall of certain lots

of Heparin Sodium USP Active Pharmaceutical Ingredient (API) due to the

identification of trace amounts of oversulfated chondroitin sulfate (OSCS)

contaminant. These lots were manufactured in 2008 and will be expiring on

October 31, 2010 and November 30, 2010.

According to an FDA safety alert, " customers who have product from the recalled

product lots in their possession should discontinue use immediately. Product lot

numbers, expiration dates, and recall instructions are listed in the Press

Release. "

FIND LOT NUMBERS HERE: http://www.fda.gov/Safety/Recalls/ucm231639.htm

If in doubt, contact your doctor or hospital.

~chris

CLL CANADA

http:/cllcanada.ca